1. Home
  2. NERV vs INTJ Comparison

NERV vs INTJ Comparison

Compare NERV & INTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • INTJ
  • Stock Information
  • Founded
  • NERV 2007
  • INTJ 2016
  • Country
  • NERV United States
  • INTJ Hong Kong
  • Employees
  • NERV N/A
  • INTJ N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • INTJ
  • Sector
  • NERV Health Care
  • INTJ
  • Exchange
  • NERV Nasdaq
  • INTJ NYSE
  • Market Cap
  • NERV 15.5M
  • INTJ 12.7M
  • IPO Year
  • NERV 2014
  • INTJ 2024
  • Fundamental
  • Price
  • NERV $1.82
  • INTJ $0.95
  • Analyst Decision
  • NERV Hold
  • INTJ
  • Analyst Count
  • NERV 1
  • INTJ 0
  • Target Price
  • NERV $5.00
  • INTJ N/A
  • AVG Volume (30 Days)
  • NERV 77.1K
  • INTJ 80.0K
  • Earning Date
  • NERV 03-04-2025
  • INTJ 11-01-2024
  • Dividend Yield
  • NERV N/A
  • INTJ N/A
  • EPS Growth
  • NERV N/A
  • INTJ 30.19
  • EPS
  • NERV N/A
  • INTJ 0.07
  • Revenue
  • NERV N/A
  • INTJ $2,341,977.00
  • Revenue This Year
  • NERV N/A
  • INTJ N/A
  • Revenue Next Year
  • NERV N/A
  • INTJ N/A
  • P/E Ratio
  • NERV N/A
  • INTJ $13.66
  • Revenue Growth
  • NERV N/A
  • INTJ 25.78
  • 52 Week Low
  • NERV $1.77
  • INTJ $0.72
  • 52 Week High
  • NERV $7.53
  • INTJ $7.87
  • Technical
  • Relative Strength Index (RSI)
  • NERV 34.70
  • INTJ N/A
  • Support Level
  • NERV $1.77
  • INTJ N/A
  • Resistance Level
  • NERV $2.05
  • INTJ N/A
  • Average True Range (ATR)
  • NERV 0.16
  • INTJ 0.00
  • MACD
  • NERV -0.04
  • INTJ 0.00
  • Stochastic Oscillator
  • NERV 6.41
  • INTJ 0.00

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About INTJ INTELLIGENT GROUP LTD

Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through IJL, its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.

Share on Social Networks: